Cancer risk in Barrett's oesophagus

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 11, 2007, Pages 915-918

  Pereira, António Dias ^a   Suspiro, Alexandra ^a   Chaves, Paula ^a  

^a EPE   (Portugal)

Author keywords

Barrett's oesophagus; Cancer risk; Intestinal metaplasia; Short segments

Indexed keywords

BARRETT ESOPHAGUS; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CANCER SURGERY; COLUMNAR EPITHELIUM; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; EPITHELIUM DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; HEALTH CARE COST; HUMAN; INTESTINE METAPLASIA; MEDICAL LITERATURE; PHOTODYNAMIC THERAPY; PRECANCER; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK ASSESSMENT;

ADENOCARCINOMA; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; HUMANS; INCIDENCE; INTESTINES; METAPLASIA; PRECANCEROUS CONDITIONS; RISK;

EID: 37349054661     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282c3a967     Document Type: Review

References (28)

1. Thomas T, Caestecker JS. Surveillance in Barrett's oesophagus. Eur J Gastroenterol Hepatol 2006; 18:585-588.
2. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997; 92:212-215.
3. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119:333-338.
4. Provenzale D, Schmitt C, Wong JB. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999; 94:2043-2053.
5. Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N. Screening and surveillance for Barrett's esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 2003; 138:176-186.
6. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992; 37:137-143.
7. Nandurkar S, Talley NJ. Barrett's esophagus: the long and short of it. Am J Gastroenterol 1999; 94:30-40.
8. Rudolph RE, Vaughan TL, Storer BE, Haggitt RC, Rabinovitch PS, Levine DS, et al. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med 2000; 132:612-620.
9. Gatenby PAC, Caygill CP, Ramus JR, Charett A, Fitzgerald RC, Watson A. Short segment columnar-lined oesophagus (CLO): an underestimated cancer risk? A large cohort study of the relationship between Barrett's CLO segments and adenocarcinoma risk. Eur J Gastroenterol Hepatol 2007; 19:969-975.
10. Sharma P, Falk GW, Weston AP, Reker D Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006; 4:566-572.
11. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993; 105:40-50.
12. Falk GW, Rice TW, Golblum JR, Richter JE. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 1999; 49:170-176.
13. May A, Grossner L, Pech O, Fritz A, Gunter E, Mayer G, et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's esophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002; 14:1085-1091.
14. Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120:1607-1619.
15. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low and high risk patient subsets. Am J Gastroenterol 2000; 95:1669-1676.
16. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123:461-467.
17. El-Serag HB, Garewal H, Kuebeler M, Sampliner RE. Is length of newly diagnosed Barrett's esophagus decreasing? The experience of a VA Health Care System. Clin Gastroenterol Hepatol 2004; 2:296-300.
18. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005; 129:1825-1831.
19. Ward EM, Wolfsen HC, Achem SR, Loeb DS, Krishna M, Hemminger LL, et al. Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am J Gastroenterol 2006; 101:12-17.
20. Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalosvki M. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol 1997; 92:407-413.
21. Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Am J Gastroenterol 1997; 92:2012-2016.
22. Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, Spechler S, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004; 127:310-330.
23. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97:1888-1895.
24. Guidelines for the diagnosis and management of Barrett's columnar lined oesophagus. A report of the working party of the British Society of Gastroenterology. 2005. Available at: http://www.bsg.org.uk. Accessed: 20 April 2007.
25. Paraf F, Flejou JF, Pignon JF. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Am J Surg Pathol 1995; 19:183-191.
26. Chandrasoma P, Wickramasinghe K, Ma Y, DeMeester T. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia? Dis Esophagus 2007; 20:36-41.
27. Oberg S, Johansson J, Wenner J, Johnsson F, Zilling T, von Holstein CS, et al. Endoscopic surveillance of columnar-lined esophagus. Frequency of intestinal metaplasia detection and impact of antireflux surgery. Ann Surg 2001; 234:619-626.
28. Ferraris R, Bonelli L, Conio M, Fracchia M, Lapertosa G, Aste H. Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopic surveillance programme. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE). Eur J Gastroenterol Hepatol 1997; 9:881-885.